Arovella Therapeutics Ltd: Notice Under Section 708A
Arovella Therapeutics Ltd: Application for quotation of securities - ALA
Arovella Therapeutics Ltd: Clinical Advisory Board established
Arovella Therapeutics Ltd: Updated Investor Webinar Presentation
Arovella Therapeutics Ltd: Investor Webinar Presentation
Arovella Therapeutics Ltd: 2024 ESG Report
Arovella Therapeutics Ltd: Corporate Governance Statement
Arovella Therapeutics Ltd: Appendix 4G
Arovella Therapeutics Ltd: Positive pre-IND feedback from FDA for ALA-101
Arovella Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Arovella Therapeutics Ltd: Zolpimist Update
Arovella Therapeutics Ltd: Arovella completes manufacturing scale-up
Arovella Therapeutics Ltd: Release of Shares from Escrow
Arovella Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report
Arovella Therapeutics Ltd: Arovella presents ALA-101 data at AACR
Arovella Therapeutics Ltd: Prof Gianpietro Dotti appointed to Scientific Advisory Board
Arovella Therapeutics Ltd: Change of Director's Interest Notice - GP
Arovella Therapeutics Ltd: Change of Director's Interest Notice - TD
Arovella Therapeutics Ltd: Change of Director's Interest Notice - MB
Arovella Therapeutics Ltd: Arovella to present at AACR annual meeting
No Data
No Data